Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||-5.26%||7.93||0.7%||$554.34m|
|GILD||Gilead Sciences, Inc.||-0.63%||69.97||1.0%||$446.95m|
|REGN||Regeneron Pharmaceuticals, Inc.||-2.27%||605.00||2.7%||$428.21m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.99%||181.60||1.9%||$247.39m|
|ISEE||IVERIC bio, Inc.||-10.97%||15.58||0.0%||$187.66m|
|LIFE||aTyr Pharma, Inc.||-1.41%||9.76||2.1%||$149.96m|
|KDMN||Kadmon Holdings, Inc.||-0.45%||8.80||0.8%||$129.86m|
Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the following segments: Proprietary Products and Distribution. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the supply of plasma-based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.